No description available.

The liver fluke, Fasciola hepatica, is one of the most important parasites of livestock, and it also infects humans. The proteolytic system of trematodes is critical for their interaction with the host and is a potential target for the development of novel vaccines. This work is focused on proteases secreted by F. hepatica adults and on FheCy2, a new protease inhibitor from the cystatin family. The proteolytic activity of the secreted proteases was analyzed using: (a) chromogenic protein substrates and fluorogenic peptide substrates, (b) selective protease inhibitors, and (c) a fluorescent activity-based probe for visualization of proteases. The results showed that the secreted proteases are cysteine proteases of papain family belonging to cathepsins L and B. These proteases were effectivelly inhibited by FheCy2 as demonstrated by enzymological analysis. It can be assumed that FheCy2 participates in the physiological regulation of endogenous proteases secreted by F. hepatica adults, which makes it attractive candidate protein for vaccination studies. Key words: Fasciola hepatica, cathepsins, proteolytic activity, substrate specificity, protease inhibitors (In Czech)

A radioterapia é um dos principais tratamentos para pacientes com câncer de cabeça e pescoço e a cárie relacionada à radioterapia é um de seus efeitos colaterais, apresentando-se com alta taxa de ocorrência. Além disso, falhas precoces em restaurações realizadas em dentes de pacientes irradiados em cabeça e pescoço também são observadas. Como a degradação enzimática do colágeno ocorre principalmente através da atividade das metaloproteinases de matriz e das cisteínacatepsinas, o objetivo deste estudo foi avaliar a atividade enzimática da dentina hígida e restaurada de dentes submetidos à radioterapia in vivo e in vitro. Os dentes irradiados in vivo foram extraídos de pacientes submetidos à radioterapia com uma dose cumulativa que variou de 40 a 70 Gy. As extrações foram feitas de 3 a 12 meses após a RT devido a doenças periodontais. Para os dentes irradiados in vitro, as amostras foram submersas em água destilada com uma irradiação total e única de 70 Gy. O estudo foi dividido em 2 fases independentes: Fase 1: Dentina Não-Restaurada (avaliação de amostras não irradiadas, dentes submetidos à radioterapia in vitro e in situ). Fase 2: Dentina Restaurada (avaliação de amostras não irradiadas e dentes submetidos à radioterapia in vitro) com 3 adesivos. Para o ensaio de zimografia (fase 1), os grupos irradiados in vitro, in vivo e não irradiados foram divididos em dois subgrupos: 1) mineralizado; 2) desmineralizado com ácido fosfórico10%. As proteínas dentinárias foram extraídas e submetidas à análise zimográfica de acordo com Mazzoni et al., 2007. Para a zimografia in situ (fase 2), os espécimes foram divididos em 6 grupos, de acordo com a forma de irradiação (não irradiada e irradiada in vitro) e o sistema adesivo testado (Adper Single Bond, 3M ESPE, ClearFil SE Bond, Kuraray ou Scotchbond Universal, 3M ESPE). Uma gelatina conjugada com fluoresceína autoextinguível foi usada como substrato para as proteases endógenas. A atividade enzimática gelatinolítica foi observada em microscópio confocal (Zeiss LSM 780-NLO, Carl Zeiss Microscopy GmbH). Para a análise da microscopia eletrônica de varredura, amostras restauradas e hígidas foram submetidas a técnica de pré-imunomarcação usando anticorpo monoclonal primário anti-CT-K e anti-CT-B, e anticorpo secundário conjugado com nano-partículas de ouro de 15nm. Um aumento na atividade gelatinolítica pós radioterapia para ambos os substratos (dentina restaurada e hígida) pôde ser observada. Houve uma maior expressão das formas ativas das MMP-2 e MMP-9 pós radioterapia para ambas as formas de radioterapia em dentina não restaurada. Nenhuma diferença na imuno-marcação para CT-K e CT-B entre os grupos irradiados e não irradiados foi observada. Adesivos autocondicionantes apresentaram uma imuno-marcação mais fraca para CT-K quando comparado ao adesivo de condicionamento total. Com isso, pode-se concluir que a radiação ionizante foi capaz de influenciar a atividade enzimática das proteínas endógenas da dentina restaurada e não restaurada. Palavras-chave: Radioterapia, metaloproteinases de matriz, MMP, cisteinocatepsinas, CT, Cárie relacionada à radiação. / Radiotherapy is one of the main treatments for head and neck cancer patients. Radiation-related caries and early restorations failures are side-effects with high rate of recurrence. As enzymatic degradation of collagen occurs mainly through the activity of matrix metalloproteinases (MMPs) and cysteine-cathepsins (CTs), the objective of this study was to evaluate the influence of in vivo and in vitro radiotherapy on endogenous proteases of the restored and non-restored dentin. In vivo irradiated teeth were extracted from patients who underwent clinical radiation protocols with a cumulative dose of radiation that ranged from 40 to 70 Gy. Extractions were performed 3 to 12 months after radiotherapy conclusion due to periodontal reasons. For the in vitro irradiated teeth, samples were submerged in distilled water with a total and single irradiation dose of 70 Gy. For gelatin zymography assay, irradiated in vivo, in vitro and non-irradiated groups were divided in two subgroups: 1) mineralized or 2) demineralized with 10% phosphoric acid. Dentin proteins were extracted and submitted to zymographic analysis in accordance to Mazzoni et al., 2007. For in situ zymography, specimens were divided into 6 groups, according to its irradiation form (non-irradiated and irradiated in vitro) and the adhesive system tested (Adper Single Bond, 3M ESPE, ClearFil SE Bond, Kuraray or Scotchbond Universal, 3M ESPE) using a self-quenched fluorescein-conjugated gelatin as the endogenous proteases substrate. The endogenous gelatinolytic enzyme activity was assessed by confocal laser-scanning microscope (Zeiss LSM 780-NLO, Carl Zeiss Microscopy GmbH). For SEM analysis of the HL, restored specimens were submitted to a pre-embedding immunolabeling technique using primary monoclonal antibody anti-CT-K and anti-CTB and a secondary antibody conjugated with 15nm gold nanoparticles. Radiotherapy groups presented increased gelatinolytic activity on both restored and non-restored dentin. MMP-2 and MMP-9 active form presented higher expression on both irradiated groups for non-restored dentin. Labeling for CT-K and CT-B did not differ from irradiated to non-irradiated groups. SE adhesives presenter weaker labeling for CT-K when compared to the E&R adhesive. Herewith, ionizing radiation may be able to influence the enzymatic activity of the endogenous proteins of restored and unrestored dentin

The mammalian embryo is encased in a glycoproteinaceous covering, the zona pellucida (ZP/zona) during preimplantation development. Prior to implantation into the recipient maternal endometrium, the blastocyst has to hatch out of this zona. This is a critical and an important event for the successful establishment of pregnancy. Hatching in mammals is characterised by the expansion of the blastocyst, followed by the nicking of the zona and extrusion of the blastocyst by repeated contraction-expansion cycles, thereby leaving the empty zona behind. In species such as the mouse, cow and primates, the empty zona is left behind in the uterine lumen. However, in the hamsters, the features associated with hatching are characteristic for this species. Firstly, the blastocyst remains predominantly in a deflated state. Secondly, the zona undergoes focal rupture which is followed by the complete dissolution of the zona. Third, trophectodermal projections (TEPs) present in the blastocysts, aid the hatching of the blastocyst. Hence, this study was aimed to identify the molecular players involved in hamster blastocyst hatching and to study their embryo-endometrial expression. Earlier work in the laboratory has demonstrated the involvement of cysteine protease-like factors in hamster blastocyst hatching (Mishra and Seshagiri, 2000a). Broad spectrum cysteine protease inhibitors, E-64 and PHMB, completely blocked the hatching of blastocysts. To identify the class of cysteine proteases involved in this phenomenon, class-specific inhibitors were used in this study. Calpain and caspase inhibitors, calpastatin and Z-VAD- FMK, respectively, did not block hamster blastocyst hatching (Fig 2.2). Cathepsin (cts)-specific inhibitors, cystatin-C and peptidyl diazomethane (PPDM) blocked hatching of embryos in a dose-, time- and embryo-stage dependant manner (Figs 2.5, 2.6, 2.10 and 2.11). Continuous exposure of 1.0 µM cystatin to expanded or deflated blastocysts completely blocked hatching (Fig 2.3Aii, iii), without effecting their viability (Fig 2.3Bii and iii). Deflated blastocysts exposed transiently to 1.0 µM cystatin, for 12 or 6 h failed to hatch, but could overcome the inhibition and exhibited hatching, when transferred to fresh, inhibitor-free medium (Fig 2.6). Effect of the inhibitor was less pronounced in the deflated blastocysts when compared to expanded blastocysts (Figs 2.5 and 2.6). The viability of the cystatin-treated embryos was not affected as assessed by vital-dye staining and also their ability to attach and exhibit trophoblast (TB) proliferation on serum-coated dishes was not compromised. The area of the TB outgrowth of cystatin-treated embryos was similar to that of the untreated embryos (Fig 2.9). The inhibitory effect of PPDM, an irreversible inhibitor of cts, on blastocyst hatching was demonstrated. Expanded and deflated blastocysts exhibited a dose-dependent inhibition in hatching, following the exposure to 0.5 and 1.0 µM of PPDM (Figs 2.10A and 2.11A). When treated with the inhibitor for 6 or 12 h, there was a transient inhibition in hatching, as blastocysts could overcome the inhibition and exhibit hatching following transfer to inhibitor-free, fresh medium. Inhibitor-treated hatched blastocysts, when transferred to serum-coated dishes, attached and exhibited TB outgrowth, similar to untreated embryos (Figs 2.13 and 2.14). A PPDM-interacting protease was localised to the cytoplasm of the embryonic cells in the hamster blastocyst, suggesting that the embryo is the source of the zona lysin. Two forms of the enzyme, a probable variant zymogen of molecular mass 65 k and an active form of molecular mass 32 k were detected in the blastocysts (Fig 2.15). In vitro susceptibility of hamster zona to cathepsins is significantly different from that of other species zonae such as the mouse, rat, monkey and human zonae (Table 2.2). All these lines of evidence unequivocally demonstrate the involvement of cathepsins in hamster blastocyst hatching, which is in sharp contrast to what is observed in the mouse, where serine proteases such as strypsin/hepsin, ISP-1 and -2 are reported to play an important role in blastocyst hatching. However, since extensive inhibitor studies were not performed using embryos from other species, it is possible that cysteine proteases maybe involved in the hatching of blastocysts from other species. Having shown the role of cathepsins in hamster zona dissolution, expression of the cathepsins in preimplantation embryos was investigated. Hamster specific cts–L, -B and –P were amplified from day 14 placenta using mouse primers and the amplicons were found to be highly homologous to the cts of other species (Fig 3.2). Hamster and mouse preimplantation embryos i.e., 8-cell, morula and blastocyst were found to express cts–L, -B and –P transcripts (Figs 3.6 and 3.10). Cts-P, present only in the TBs of the placenta (Fig 3.4), for the first time, was also shown to be present in the preimplantation embryos. The immunoreactive cts-L and -P proteins were detected in blastomeres of 8-cell embryo, in the inner cell mass (ICM) and trophectoderm (TE) of the blastocyst (Figs 3.7 and 3.8). These cathepsins could probably correspond to the PPDM- interacting enzymes of molecular mass 32 and 65 kDa, described above. (fig) Fig 5.1. Overview of the expression and the role of embryo-endometrial cathepsins in blastocyst hatching in the golden hamster. Cathepsins ( ) produced by the inner cell mass ( ) or the trophectoderm ( ) of the blastocyst or the endometrial cells ( ) act on the zona matrix ( ), bringing about its lysis. The cathepsins are secreted into the peri-vitelline space or are carried by trophectodermal projections (TEPs, yellow projections) to the zona. Also shown are endogenous inhibitors and growth factors that can regulate these cathepsins. A striking observation made in this study was the detection of the immunoreactive signals for cathepsins in the zona matrix of blastocysts. Since hamster blastocysts possess extracellular projections (TEPs), it is possible for these projections to participate in the transport of cathepsins from TE cells to the zona; as the localisation of the proteases to these projections was demonstrated (Fig 3.9). Also, since the actin-based projections are highly undulating structures, they might potentiate the mechanical rupture of the zona during hatching, apart from acting as carriers for the proteases. Hence, during hatching of the hamster blastocyst, cathepsins, expressed in the ICM and the TE, might be secreted transiently into the peri-vitelline space, whereby they can act on the ZP. Alternatively, in the absence of any apoptotic cells in the embryo that can release the cell contents (Fig 3.13), the cathepsins may be deposited by TEPs in specific pockets of the zona matrix, thereby causing focal zona lysis. In vivo, the hatching of the blastocysts is brought about by both embryonic and maternal proteases. Cts–L and -B transcripts were detected in the maternal endometrium during different stages of the reproductive cycle and early pregnancy (Fig 4.1 and 4.3). Immunoreactive cts-L protein was detected in the uterine luminal epithelium and the stromal cells (Fig 4.5). In the uterus, the PPDM-interacting 32 kDa form was in abundance compared to the 65 kDa form (Fig 4.6). Hence, uterine cathepsins might play a major role in the remodelling of the extracellular matrix during estrous cycle and pregnancy. However, the role of these cathepsins in causing zona dissolution during blastocyst hatching, along with embryonic proteases cannot be ruled out. Reports of recurrent miscarriages in women with low serum cystatin levels imply a role for cysteine proteases in early pregnancy events like blastocyst development, hatching and implantation. Hence, these studies, described in the thesis, could form a basis to investigate the role of cathepsins in early human development. Taken together, the results demonstrate the involvement of embryo-derived cathepsins in hamster blastocyst hatching. These cathepsins may be secreted into the peri-vitelline space or transported to the zona matrix by TEPs (Fig 5.1). Additionally, in vivo, endometrial cathepsins might aid the embryonic zona lysins in the complete zona dissolution. The regulation of these proteases by growth factors, cytokines and their specific inhibitors needs to be explored. (For figure pl see the original document)

Le récepteur-canal P2X7 est fortement exprimé et est fonctionnel dans la lignée de cellules cancéreuses mammaires humaines hautement invasives MDA-MB-435s. L’activation de P2X7 par l’ATP extracellulaire est responsable de l'émission des prolongements cellulaires et l'augmentation de la migration cellulaire. En outre, l’activation de P2X7 augmente l’invasion cellulaire à travers la matrice extracellulaire et fait intervenir la libération de forme mature de cathepsines à cystéine dans le milieu extracellulaire. L’inhibition pharmacologique de P2X7 diminue l’invasivité des cellules cancéreuses dans un modèle de micrométastases chez le poisson zèbre. Nous avons également montré que l’émodine (1,3,8-trihydroxy-6-méthylanthraquinone) une anthraquinone isolée de Rheum officinale Baill (Rhubarbe chinoise) inhibe l’invasivité des cellules cancéreuses humaines via l’antagonisme de P2X7 et n’as pas d’effet sur les autres récepteurs P2X. Nos résultats démontrent un nouveau mécanisme entre la fonctionnalité de P2X7 dans les cellules cancéreuses et l’invasivité cellulaire, un paramètre clé dans la croissance tumorale et le développement des métastases. Ceci suggère également un rôle thérapeutique potentiel pour les antagonistes des P2X7. / P2X7 receptor channel is highly expressed and fully functional in the highly invasive human breast cancer cell line MDA-MB-435s. Its activation by extracellular ATP is responsible for the extension of neurite-like cellular prolongations, and the increase in cell migration. Furthermore, P2X7 activation enhanced invasion through the extracellular matrix and was related to the increase of mature forms of cysteine cathepsins in the extracellular medium. Pharmacological targeting of P2X7 decreases cancer cell invasiveness in a zebrafish model of micrometastases. We also showed that emodin (1,3,8-trihydroxy-6-methylanthraquinone) an anthraquinone derivative originally isolated from Rheum officinale Baill (Chinese Rhubarb) inhibits human cancer cell invasiveness by specifically antagonizing the P2X7 and not the other members of the P2X family. Our results demonstrate a novel mechanistic link between P2X7 functionality in cancer cells and invasiveness, a key parameter in tumour growth and in the development of metastases. These results also suggest a potential therapeutic role for the newly developed P2X7 antagonists.

Le renouvellement de la membrane basale et de la matrice extracellulaire lors de processus physiologiques ou pathologiques (réparation tissulaire, angiogenèse, inflammation, cancer) fait intervenir de nombreuses protéases dont les cathepsines à cystéine. Après avoir étudié leur localisation dans l’épiderme à proximité de la jonction dermo-épidermique et leur sécrétion par les kératinocytes, nous avons montré la capacité de la cathepsine S à dégrader efficacement les principales protéines de la membrane basale (laminine, collagène IV, perlécan) et plus particulièrement le nidogène-1, qui est essentiel à l’organisation architecturale de la membrane basale via de multiples interactions avec les autres constituants. Parmi plusieurs glycosaminoglycanes présents dans la matrice extracellulaire, le chondroïtine 4-sulfate est capable de se complexer avec la cathepsine S, via trois sites potentiels de fixation dont un au niveau de son site actif, et d’inhiber son activité enzymatique de façon dose-dépendante. L’expression et l’activité de la cathepsine S au niveau de l’épiderme diminuent au cours du vieillissement cutané, alors que l’expression du nidogène-1 reste stable. La cathepsine S jouerait donc un rôle important aux côtés d’autres protéases dans le remodelage de la membrane basale. / Basement membrane (BM) and extracellular matrix (ECM) turnover during physiological or pathological events (tissue repair, angiogenesis, inflammation, cancer) involves numerous proteases including cysteine cathepsins. Cathepsins expression in skin epidermis near dermal-epidermal junction and their secretion by keratinocytes were first analyzed. We showed that cathepsin S degrades efficiently main BM components (laminin, type IV collagen, perlecan) and particularly nidogen-1 that is essential for BM architecture. Among several glycosaminoglycans present in ECM, chondroïtin 4-sulfate is able to form a stable complex with cathepsin S. Three predicted binding sites including one closed to its active site were identified. Further, C4-S inhibits cathepsin S activity in a dose-dependent manner. The expression and activity of cathepsin S in epidermis are decreased upon skin aging while nidogen-1 expression remains unchanged. Cathepsin S besides other proteases may play an important role in BM remodeling.

Lors de la fibrose pulmonaire idiopathique (FPI), la différenciation fibroblastique s’accompagne d’une accumulation excessive des composants de la matrice extracellulaire ainsi qu’à un dérèglement de la balance protéases / antiprotéases. Nous avons étudié le rôle des cathepsines à cystéine dans la myofibrogenèse et leur contribution potentielle à la physiopathologie de la fibrose pulmonaire chez l’Homme. Pour cela, le profil d’expression des cathepsines ainsi que de leurs inhibiteurs naturels a été évalué dans un modèle cellulaire expérimental, puis dans des myofibroblastes primaires et enfin dans des liquides de lavage broncho-Alvéolaires (LBA) de patients atteints de FPI. Nos résultats montrent que lors de la FPI la cystatine C (inhibiteur naturel des protéases à cystéine) régule les activités protéolytiques des cathepsines extracellulaires et pourrait ainsi contribuer à l’accumulation de collagènes. Elle serait un biomarqueur potentiel de la FPI. D’autre part la cathepsine B participe à la différentiation fibroblastique et son inhibition retarde la myofibrogenèse. / During idiopathic pulmonary fibrosis (IPF), fibroblast differentiation is accompanied by an excessive accumulation of extracellular matrix components as well as an imbalance between proteases and theirs inhibitors. We evaluated the role of human cysteine cathepsins in myofibrogenesis and their potential contribution to the pathogenesis of IPF. Expression of cathepsins and their natural inhibitors have been studied in an experimental cell model, but also in primary myofibroblasts and in bronchoalveolar lavage fluids (BALF) of patients suffering from IPF. Our results show that cystatin C (a natural inhibitor of cysteine proteases) regulates the extracellular proteolytic activities of cathepsins and could contribute to the accumulation of collagens. Cystatin C could also be a potential biomarker of IPF. On the other hand, cathepsin B participates in fibroblast differentiation and its inhibition delays myofibrogenesis.

IN ENGLISH Charles University Faculty of Pharmacy in Hradec Králové Department of Biological and Medical Sciences Supervisors: prof. Dr. Michael Gütschow RNDr. Klára Konečná, Ph.D. Candidate: Michaela Hympánová Title of the diploma thesis: Enzyme kinetic evaluation of several potential inhibitors of certain human cysteine and serine proteases Background Cysteine and serine proteases are enzymes involved in many physiological processes. The imbalance between them and their endogenous inhibitors is associated with various diseases such as cancer and osteoporosis. Synthetic inactivators could be useful in the treatment of these enzyme-mediated pathological conditions. Therefore, there are ongoing attempts to develop low-molecular weight inactivators for therapeutically relevant cysteine and serine proteases. In the course of this thesis, compounds synthesized in prof. Gütschow's group were investigated as potential inhibitors of selected human proteases. They belong to imidazole compounds derived from N-protected cyclohexylalanine, 2-phenyl-7,8-dihydroimidazo[1,2- a]pyrazin-6(5H)-one derivatives, ,-unsaturated peptidomimetic compounds, carbamates, an N,N-dibenzylcrotonamide derivatives and peptoides. Aims This diploma thesis has been focused on the evaluation of new potential inhibitors against...

No description available.

Die Cathepsine B, H und L sind lysosomale Enzyme, die zur Gruppe der Cysteinproteasen gehören. Erhöhte Aktivitäten dieser Proteasen fand man in Gewebeproben verschiedener Tumore, vermutlich Hinweis auf eine Beteiligung an Invasion und Metastasierung. Unter physiologischen Bedingungen werden die Cathepsine von endogenen Inhibitoren kontrolliert, eine Verminderung dieser Cysteinprotease-Inhibitoren (CPI) würde die proteolytische Dysbalance verstärken und zur Ausbreitung des malignen Prozesses beitragen. Für das Prostatakarzinom gab es bisher keine Untersuchungen. Die Aktivität der Cathepsine wurde mit Hilfe spezifischer Substrate bestimmt, die zur Bildung fluorogener Produkte führten. Zur Bestimmung der inhibitorischen Aktivität der CPI wurden die Proben nach einer Hitzeaktivierung gegen reines Cathepsin B getestet. Untersucht wurden Gewebeproben verschiedener Patientengruppen, Primärzellkulturen, die aus normalem und maligne veränderten Prostatagewebe angezüchtet wurden und vergleichend dazu die drei immortalisierten Zellinien LNCaP, PC3 und DU145. Die Ergebnisse der Gewebeproben zeigten höhere Aktivitäten der Cathepsine B und L im nichterkrankten Gewebe, nicht wie erwartet im Tumorgewebe der Prostata. Hingegen waren bei den Primärzellkulturen alle drei Cathepsine und der Quotient Cathepsine/CPI in den Tumorproben erhöht. Die immortalisierten Zellinien zeigten die gleiche Verteilung bei allen Cathepsinen, DU145 mit der höchsten Aktivität, gefolgt von LNCaP und PC3. Anhand der Ergebnisse schlußfolgern wir, daß die Untersuchung von Gewebe-proben der Prostata hinsichtlich der Beteiligung der Cathepsine am Tumor-geschehen keine eindeutigen Erkenntnisse erbringt. Dies ist vermutlich auf die Heterogenität des Gewebes zurückzuführen, das nicht nur epitheliale, sondern auch stromale Zellen enthält. Die aus dem Gewebe angezüchteten Primär-zellkulturen scheinen ein genaueres Bild des Verhältnisses von Cathepsinen und den Inhibitoren zu geben und sind unserer Meinung nach den Bestimmungen in Gewebeproben vorzuziehen. / The cathepsins B, H and L (CB, CH, CL) are lysosomal proteolytic enzymes belonging to the cysteine protease family. Elevated cathepsin levels and decreased concentration of their endogenous inhibitors have been demonstrated in a variety of tumors, suggesting a contribution to invasion and metastasis. The situation for prostate cancer was so far unknown. Using fluorimetric assays, catalytic activities of the cathepsins B, H, L were measured in prostatic tissue samples obtained from different groups of patients, in primary cell cultures established from human prostate and in the immortalized cell lines LNCaP, PC3 and DU145. Inhibitory activities of cysteine protease inhibitors (CPI) were tested against purified cathepsin B. Comparing matched pairs of normal and cancerous tissue samples from the prostate, significantly decreased levels of CB and CL were found in malignant samples. In contrast, primary cell cultures from malignant tissue showed elevated levels of all three cathepsins and increased ratios of cathepsins to CPI when compared to cell cultures from non-malignant prostate. The permanent cell lines showed a similiar distribution of cathepsin levels, DU145 with the highest activity, followed by LNCaP and PC3. These results suggest that elevated cathepsin activities and increased ratios of cathepsins to CPI in malignant cell cultures compared to non-malignant samples may be an indication for a cellular proteolytic imbalance in prostatic cancer cells. Regarding different results, determinations in primary cell cultures should be preferred to tissue samples.